A Randomized, Double-Blind, Non-Inferiority Study of Hydromorphone Hydrochloride Immediate-Release Tablets Versus Oxycodone Hydrochloride Immediate-Release Powder for Cancer Pain: Efficacy and Safety in Japanese Cancer Patients.
Japanese journal of clinical oncology（2018）
摘要
The non-inferiority of hydromorphone compared with oxycodone for the treatment of cancer pain was confirmed in 183 Japanese cancer patients. Hydromorphone and oxycodone had similar efficacy and safety profiles.
更多查看译文
关键词
hydromorphone,oxycodone,cancer pain,palliative medicine,double-blind study
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要